"膜杰作"——四次跨膜蛋白Claudin18.2(HEK293 表达)

Claudin蛋白家族由Furuse于1998 年首次发现,是一类存在于上皮和内皮紧密连接处的四次跨膜蛋白,其作用是维持控制细胞间分子交换的紧密连接,包含至少27个成员。Claudin18.2 作为Claudin 18的亚型之一,在正常组织中仅有限表达于胃黏膜的分化上皮细胞,而在胃癌、胰腺癌、胆管癌、卵巢癌和肺癌等多种恶性肿瘤组织中的表达水平显著提升,是目前为止Claudin家族中最受关注的靶点。靶向Claudin 18.2的药物类型包括单克隆抗体、双特异性抗体、ADC以及CAR-T疗法。
多次跨膜蛋白受限于细胞膜的表面积,且作为介导膜内外信息传递的主要工具之一,过表达的多次跨膜蛋白通常具有细胞毒性,因此即使重组表达的多次跨膜蛋白的表达量也远低于可溶性蛋白。此外,在提取和纯化的过程中需要筛选合适的去垢剂或脂分子来保持空间构象和蛋白活性,使得获得高纯度的具有天然构象和活性的多次跨膜蛋白非常困难。没有理想抗原Claudin18.2,大大限制了靶向Claudin18.2的药物及疗法开发。
为解决四次跨膜蛋白Claudin18.2难以获取完整构象的挑战,ACROBiosystems百普赛斯利用"膜杰作"—多次跨膜靶点蛋白开发技术平台 ,成功开发了全长Claudin18.2-VLP、完整表位Claudin18.2-Detergent及无去垢剂Claudin18.2-Nanodisc产品,经ELISA/BLI/SPR验证具有高生物活性,可满足药物开发需求。同时,我们还可提供Claudin18.2稳定细胞株SPR&BLI分子互作服务,助力抗体药物开发及临床申报。
Claudin18 三维结构(AlphaFold预测图)

产品列表

VLP平台
Nanodisc平台
Detergent平台

Claudin18.2全系列产品

以下ELISA/SPR/BLI/FACS数据均可免费提供内部实验操作方法以供参考,点击申请Protocol即可获取。

高免疫原性
Claudin18.2-VLP
(CL2-H52P7CL2-HF218)
Claudin18.2-VLP
产品优势
天然完整构象:全长Claudin 18.2蛋白在VLP中保持天然构象,提高抗体结合特异性
高免疫原性:VLP平台提高了靶抗原的丰度,增强了免疫效果
多领域应用:可用于免疫/ELISA/SPR/BLI/细胞实验/CAR阳性率检测
完整构象
Claudin 18.2-Detergent
(CL2-H5587,CL2-H85D3)
Claudin18.2-DDM/CHS
产品优势
天然构象与活性:去垢剂DDM/CHS(DC-11)经工艺筛选,保持Claudin 18.2蛋白的天然构象和活性
生物素标记:提供生物素标记的Claudin18.2蛋白(CL2-H85D3),方便后续实验操作
经验证蛋白活性良好:可应用于免疫/ELISA/SPR/BLI
高稳定性
Claudin 18.2-Nanodisc
(CL2-H85D4,CL2-H5586)
Claudin18.2-DDM/CHS
产品优势
天然膜环境:Nanodisc平台模拟细胞膜环境,保持Claudin 18.2蛋白的膜结合特性
高稳定性与活性:提供稳定且高活性的Claudin 18.2蛋白
适用于免疫/ELISA/SPR/BLI/细胞实验/CAR阳性率检测
高表达量
Claudin18.2-稳定细胞株
CHEK-ATP033
Claudin18.2-稳定细胞株
产品优势
稳定表达:经过2个月传代验证,稳定表达Claudin 18.2
高活性验证:经FACS验证,Claudin 18.2稳定细胞株与抗Claudin 18.2抗体特异性结
可用于免疫/细胞水平的抗体筛选
Claudin 18.2-VLP
验证数据1
Claudin18.2-VLP(CL2-H52P7
CL2-H52P7
验证数据2
经ELISA验证,全长Claudin18.2-VLP(CL2-H52P7)可与抗Claudin18.2抗体特异性结合,线性区间为0.2-3 ng/mL
ELISA

Immobilized Human Claudin-18.2 Full Length Protein-VLP (Cat. No. CL2-H52P7) at 5 μg/mL (100 μL/well) can bind Monoclonal Anti-Chimeric Claudin-18.2 Antibody, Human IgG1 with a linear range of 0.2-3 ng/mL (QC tested).

Protocol

验证数据3
经SPR验证, Claudin18.2-VLP(CL2-H52P7)可与抗Claudin18.2抗体特异性结合,亲和力常数为0.374 nM
SPR

Human Claudin-18.2 Full Length Protein-VLP (Cat. No. CL2-H52P7) captured on CM5 Chip via Anti-Claudin-18.2 antibody can bind Anti-Claudin-18.2 antibody with an affinity constant of 0.374 nM as determined in a SPR assay (Biacore T200) (Routinely tested).

验证数据4
经FACS验证,用Human Claudin18.2-VLP 蛋白(Cat. No. CL2-HF218)和阴性对照蛋白(Cat. No. VLP-NF2P4)分别结合转染Claudin18.2-CAR-293细胞,
结果表明,Claudin18.2-VLP 蛋白(Cat. No. CL2-HF218)可与Claudin18.2-CAR-293细胞特异性结合。
ELISA

2e5 of Anti-Claudin-18.2 CAR-293 cells were stained with 100 μL of 3 μg/mL of Fluorescent Human Claudin-18.2 Full Length Protein-VLP (Cat. No.CL2-HF218) and negative control protein respectively, FITC signals was used to evaluate the binding activity (Routinely tested).

Protocol

Claudin18.2-Detergent
验证数据1
经ELISA验证, Claudin18.2- DDM/CHS(CL2-H5587),可与抗Claudin18.2抗体特异性结合,线性区间为0.1-2 ng/mL
ELISA

Immobilized Human Claudin-18.2, His,Twin-Strep Tag (Cat. No. CL2-H5587) at 2 μg/mL (100 μL/well) can bind Monoclonal Anti-Chimeric Claudin-18.2 Antibody, Human IgG1 with a linear range of 0.1-2 ng/mL (QC tested).

Protocol

验证数据2
经SPR验证, Claudin18.2-VLP(CL2-H5587)可与抗Claudin18.2抗体特异性结合,亲和力常数为6.72 nM
SPR

Anti-Claudin-18.2 mAb captured on CM5 chip via anti-Human IgG (Fc) antibody can bind Human Claudin-18.2, His,Twin-Strep Tag (Cat. No. CL2-H5587) with an affinity constant of 6.72 nM as determined in a SPR assay (in presence of DDM and CHS) (Biacore T200) (Routinely tested).

Protocol

Claudin18.2-Nanodisc
验证数据1
经ELISA验证,全长Claudin18.2-Nanodisc(CL2-H85D4)可与抗Claudin18.2抗体特异性结合,线性区间为0.1-2 ng/mL
ELISA

Immobilized Biotinylated Human Claudin-18.2 Protein, His,Avitag&Flag Tag (Cat. No. CL2-H85D4) at 1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Monoclonal Anti-Chimeric Claudin-18.2 Antibody, Human IgG1 with a linear range of 0.1-2 ng/mL (QC tested).

Protocol

验证数据2
经SPR验证, 全长Claudin18.2-Nanodisc(CL2-H5586)可与抗Claudin18.2抗体特异性结合,亲和力常数为12.6 nM
SPR

Monoclonal Anti-Chimeric Claudin-18.2 Antibody, Human IgG1 captured on Protein A Chip can bind Human / Cynomolgus Claudin-18.2, His,Twin-Strep Tag (Cat. No. CL2-H5586) with an affinity constant of 12.6 nM as determined in SPR assay (Biacore 8K) (Routinely tested).

Protocol

高活性Claudin18.2-稳定细胞株
验证数据
经FACS验证,Anti-Claudin18.2抗体可与HEK293/ Claudin18.2稳定细胞株(CHEK-ATP033)特异性结合。
Claudin18.2稳定细胞株

FACS analysis of cell surface expression of Claudin-18.2 on HEK293/Human Claudin-18.2 Stable Cell Line(Cat. No. CHEK-ATP033). 0.2 million of untransfected HEK293 cells (grey line ) and HEK293/Human Claudin-18.2 stable cells (red line ) were stained with 100 µL of the diluted solution of anti-Claudin-18.2 antibody, Human IgG1 ,washed and then followed by PE anti-Human IgG1 Fc antibody and analyzed with flow cytometry .

Protocol

临床药物信息

相关参考文献

Jumper J, et al. Highly accurate protein structure prediction with AlphaFold. Nature (2021)

Furuse M, et al. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin[J]. J Cell Biol(1998)

  • 背景
  • 产品列表
  • Claudin18.2全系列产品
  • 临床药物信息
  • 相关参考文献